Advertisement
Singapore markets closed

  • Straits Times Index

    3,287.75
    -5.38 (-0.16%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • Dow

    38,460.92
    -42.77 (-0.11%)
     

  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     

  • Bitcoin USD

    63,727.27
    -2,848.73 (-4.28%)
     

  • CMC Crypto 200

    1,361.83
    -20.74 (-1.50%)
     

  • FTSE 100

    8,100.34
    +59.96 (+0.75%)
     

  • Gold

    2,337.30
    -1.10 (-0.05%)
     

  • Crude Oil

    83.19
    +0.38 (+0.46%)
     

  • 10-Yr Bond

    4.6630
    +0.0110 (+0.24%)
     

  • Nikkei

    37,628.48
    -831.60 (-2.16%)
     

  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     

  • FTSE Bursa Malaysia

    1,569.25
    -2.23 (-0.14%)
     

  • Jakarta Composite Index

    7,155.29
    -19.24 (-0.27%)
     

  • PSE Index

    6,574.88
    +2.13 (+0.03%)
     

Reckitt Benckiser affirms full-year targets

Reuters
Products produced by Reckitt Benckiser; Vanish, Finish, Dettol and Harpic, are seen in London February 12, 2008. REUTERS/Stephen Hird

LONDON (Reuters) - Reckitt Benckiser (RB.L) reported slightly better than expected quarterly sales on Monday and affirmed its full-year forecast after a severe flu season boosted sales of medicines and other health products.

The British maker of Mucinex cold medicine, Dettol soaps and Durex condoms said that like-for-like sales rose 5 percent in the first quarter. Analysts on average were expecting an increase of 4.9 percent.

The company said it is still on track for full-year growth of 4 percent to 5 percent and for its operating margin to expand at a "moderate" rate in the medium term.

(Reporting by Martinne Geller in London; Editing by David Goodman)